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The binding of aM-triamcinolone acetonide to soluble 
macromolecules of cultured human skin fibroblasts was 
studied in an attempt to explain the mechanism under-
lying the inhibitory effects of glucocorticoids on cell 
growth. The results were as follows: 
Cultured human skin fibroblasts contain in cytosol a 
high affinity binding system for glucocorticoids. Various 
glucocorticoid derivatives competed for specific binding 
of 3H-triamcinolone acetonide. In some but not all in-
stances this competition was r elated to the clinical effi-
cacy of the derivatives under study and to their potency 
for the inhibition of cell growth. 
A specific glucocorticoid binding system was detecta-
ble in steroid-sensitive, low-density cell cultures (appar-
ent Bmux = 200 fmoles/mg protein). The number of steroid 
binding sites was lower in high-density cell cultures 
(apparent Bmux = 125 fmoles/mg protein). The sensitivity 
to growth inhibition by glucocorticoids was markedly 
decreased in the high-density cell cultures. There were 
no differences in the affinity constants between these 
cell cultures (Kdiss. = 3.3 X 10- 9 M). 
When cells w ere grown in medium containing gluco-
corticoid, renewal of the incubation medium led to dis-
appearance of the growth-inhibitory effects, whereas 
specific binding was not affected. · 
Nandrolone, an inhibitor of cell growth, abolished the 
growth-inhibitory effects of glucocorticoids but did not 
displace 3H-triamcinolone acetonide from its binding 
sites. 
The results suggest that in addition to a mechanism 
mediated by a glucocorticoid binding system with recep-
tor like properties also other factors as well appear of 
relevance for the control of cell growth. These factors 
may be beyond the actual binding process of steroid and 
involve the action at the level of genomic expression of 
the cell. 
Glucocorticoids used for topical application in th e t reatm ent 
of various skin diseases were found to induce a transient inhi-
bition of the proliferation of cultured huma n skin fibroblasts 
[1,2]. This inhibition, which occurred in t he early growth stage, 
was m aximal in the first few days after plating a nd decreased 
with progressive cell proliferation. At high cell density, fibro-
blast growth even became insensitive to the glucocorticoids. In 
confluen t cultmes the glucocorticoids inhibited collagen syn-
t hesis specifically (3,4], whereas total protein synthesis was 
hardly a ffected. 
The glucocorticoids inhibi ted cell proliferation as well as 
collagen synthesis by cultured huma n skin fibroblast at concen-
trations approximating those expected in dermis during the 
topical treatment of skin disorders. The order of effectivity of 
glucocorticoids in the inhibi t ion of cell proliferation a nd colla -
gen synthesis roughly parallels that of th erapeu t ic a nd atrophic 
effects observed clinically. 
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The inhibi t ion of cell proliferation in th e early growth stages 
was transient a nd was strongest when the culture m edium was 
not renewed [2]. This transient character of the inhibit ion was 
not due to th e development of steroid-resistant cell lines, be-
cause new generations produced by steroid-insensitive cells did 
not show t his Jack of sensi t ivi ty. 
The action of glucocorticoids is postulated to occm via bind-
ing to a receptor system presen t in the cytosol. The decreased 
sensitivity of cells to the steroid-induced inhibition of cell 
proliferation at high cell density might ther efore be due to 
reduced r esponsiveness of th e glucocorticoid-receptor system. 
The aim of the study r eported in this paper was to charac-
terize the intracellular glucocorticoid -receptor system of cul-
t ured huma n skin fibroblast a nd to compare th e specific binding 
of 3H-triamcinolone acetonide to sites originating from cells 
grown to a steroid-insensitive, high cell density with that of 
cells grown to a steroid-sensitive, low cell density. In addition, 
the specific binding of cells grown in th e presen ce or absence of 
glucocor t icoids was investigated. Finally, t h e binding of various 
glucocorticoids used topically was a nalyzed in relation to their 
clinical efficacy a nd a bility to cause atroph y. 
MATERIALS AND METHODS 
The fibrob lasts were obtained from biopsies of normal infant fore-
skin, and 7 to 15 passages were used for the experiments; plastic Petri 
dishes (0 145 mm) were inocu lated with 2 X lOG fibroblasts in 20 ml 
Ham's F 10 medium supplemented with 15% newborn calf serum, 
penicillin (100 U/ ml) , and streptomycin (100 mg/ ml) . The cells were 
grown in an atmosphere of 5% COt and 95% air, and the growth medium 
was renewed twice a week. 
The cells were harvested by trypsinization (0.25% trypsin, 0.02% 
EDTA in PBS, pH 7.2) on either day 1 (low cell density) or day 7 (high 
cell density). For the competitive binding experiments, the cells were 
harvested on day 7. In the experiments done to study the insensitivity 
of cells to glucocorticoids, t he cells were supplied on day 1 with medium 
containing either 0.5 Ill ethanol/ml medium or 1 llg clobetasol-17-
propionate/ ml, and incubated un til day 5. Clobetasol-1 7-propionate 
was dissolved in ethanol, after which 0.5 !lllml medium was added. To 
remove the glucocorticoid from the cells grown in the presence of 
clobetasol-17-propionate, they were incubated at 37°C for up to 72 tu· 
in steroid-free medium before trypsinization. 
The harvested cells were centrifuged for 10 min at 500 xg, washed 
3 ti mes with ice-cold PBS, and centrifuged at 500 Xg. The washed cells 
were resuspended (approximately 4 x 107 cells/ ml) in a homogenization 
buffer (5 mM Tris-HCl, 1 mM EDTA, 1 mM mercaptoethanol, and 5% 
glycerol; pH 7.4), and homogenized at 0°C with 30 strokes of a Tefl on 
pestle in a glass vessel. The homogenate was centrifuged at 2°C for 1 
hr at 105,000 g,v in an International Bw ul tracentrifuge for the prepa-
ration of cytosol. 
For the binding studies, homogenates were incubated with various 
concentrations of '1H-triamcinolone acetonide (45 C;/mMol, Radi-
ochemical Centre Amersham) up to 2 X w-" M triamcinolone acetonide. 
To measure the nonspecific binding 10_,, M unlabeled triamcinolone 
acetonide was added to the incubate containing the labeled steroid. 
The final incubation volume was 0.4 ml originating from approximately 
1.5-2 x 107 cells. The labeled steroid was added in 20 Ill ethano l. 
For the competition experiments, cytosol was incubated with 2 x 
w-• M triamcinolone acetonide with or without competing steroids at 
concentra tions of 10- " to 10- 7 M. The ethanolic solu tions of steroids 
were dried under aspiration before the addition of 0.4 ml cytosol. For 
the competitive binding experiments, the fo llowing steroids were used: 
hydrocortisone (l7a-hydroxycorticosterone,H, Nogepha, Alkmaar, T he 
Netherlands), hydrocortisone- 17-butyrate (17a-butyrate corticoster-
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one,H-17-B, Gist Brocades*), triamcinolone acetonide (9a:-fluoro-16a:-
hydroxyprednisolone acetonide, TAAc, Lederle), betamethasone-17-
valerate (9a:-fluoro-16,8-methyl-prednisolone-17 -valerate, B-17-V, 
Glaxo*), clobetasol-17-propionate (21-chloro-9a:-fluoro-16,8-methyl pro-
pionate prednisolone; C-17-P; Glaxo*), and nandwlone (19-nortestos-
terone,N, Organon •). 
All incubations were carried out for 3 hr at 0°C. Steroid bound to 
the proteins was separated from unbound steroids on columns of 
Sephadex LH 20 [5). After sampling of the eluate for protein determi-
nation [6] 6 ml of scintillation fluid (4 g PP0/1,toluene : Triton X 100 
2 : 1) was added to the remaining eluate and counted at counting 
efficiency of about 40%. 
RESULTS 
In a preliminary series of experiments some general charac-
teristics of the steroid binding to the soluble proteins of our 
cultured human skin fibroblasts were investigated. The specific 
binding sites in the cytosol were saturated at concentrations of 
about 2 x 10- 8 M triamcinolone acetonide (see Fig 2). The 
amount of specifically bound steroid did not vary significantly 
with protein concentrations in the cytosol ranging from 20-200 
J.Lg/sample. Incubation of cytosol for 3 hr at 0°C with 3H-
triamcinolone acetonide and both with and without competing 
steroid appeared sufficient to reach binding equilibrium. No 
changes in amount of specifically bound triamcinolone aceto-
nide in the presence or absence of competing steroids were 
observed between the 2nd and 19th hr of incubation. 
To compare the binding of topically applied glucocorticoids 
with their clinical and growth-inhibitory efficacy, the displace-
ment of specifically bound 3H-triamcinolone acetonide by var-
ious glucocorticoids was studied (Fig 1) . The same order of 
displacement in the concentration range from 10- 8 M to 10- 7 M 
of competing steroid was observed in 3 experiments. Hydrocor-
tisone was the least potent competitor, followed by hydrocor-
tisone-17 -butyrate. Betamethasone-17 -valerate and clobetasol-
17-propionate showed the same potency as triamcinolone ace-
tonide alone. The anabolic steroid (nandrolone), which abol-
ished the inhibitory effect of clobetasol-17 -propionate on fibro-
blast proliferation [7), did not compete with 3H -triamcinolone 
acetonide for the specific binding sites. 
The experiments concerning the influence of glucocorticoids 
on the rate of cell proliferation differences in the sensitivity of 
the cells were observed depending on cell densities [2). There-
fore, binding of glucocorticoids to receptors was analyzed for 
cell cultures characterized by a low or high cell density (2.3 x 
10n and 11 x 10u cells/ dish, respectively). The results of this 
comparison are shown in Fig 2, from which it is evident that 
considerable specific bincting occurred in both the low and the 
high cell density cultures. There is, however, a difference be-
tween the cells in the 2 growth stages with respect to the 
number of available binding sites/mg protein: the apparent 
B,,.,.x = 200 fmoles/mg protein for low and 125 fmoles/mg 
protein for high cell density cultures. The apparent dissociation 
constant did not differ significantly; Kdi•.<. being 3.3 X 10- 9 M for 
both types of culture. 
As reported elsewhere [2], growth inhibition of fibroblasts in 
the presence of glucocorticoids was found to be transient. 
Renewal of the growth medium in cultures grown in the pres-
ence of steroid could abolish the steroid inhibition even when 
the medium contained the fresh dose of glucocorticoid. The 
inhibitory action of the steroid therefore seems to cease with 
the disappearance of a presumptive factor involved in growth 
inhibition and/or with the appearance of a defect in the binding 
system itself. To find out whether this phenomenon could be 
explained by a modulated binding process the following exper-
iment was perform ed. Fibroblasts were grown in the presence 
of 1 J.Lg clobetasol-17 -propionate or 5 J.Lg triamcinolone aceto-
nide/ml medium from day 1 to day 5, incubated for either 1 or 
* We thank Gist-Brocades, Glaxo, and Organon for kindly providing 
us with these steroids. 
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FIG 1. Displacement of bound 3H-triamcinolone acetonide by var-
ious unlabeled forms of steroid present at concentrations between w-s 
and w-n M. Representative data of 3 experiments. H: hydrocortisone; 
H-17-B: hydrocortisone-17-butyrate; C-17-P: clobetasol-17-propionate; 
TAAc: triamcinolone acetonide, B-17- V: betamethasone-17-valerate, N: 
nandrolone. 
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FIG 2. Concentration · dependence of the specific binding of "H-tri-
amcinolone acetonide to the glucocorticoid receptor in cytosol of fibro-
blasts grown to a low cell density (2.3 X 10'; cells/dish), and a high cell 
density (11 x IOn cells/dish, o). 
16 hr in steroid-free medium at 37°C, harvested, and homoge-
nized, after which binding with '~H-triamcinolone acetonide was 
assessed. Under these conditions we were unable to detect any 
specific binding of 3H-triamcinolone acetonide, even when the 
incubation time in steroid-free medium was prolonged to 72 hr. 
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To find out whether incubat ion in steroid-free medium for 
these periods was sufficient for removal of all steroid present in 
the cells, the following experiment was performed. The cells 
were first incubated for 3 days in the presence of 5 t-tg triamcin-
olone acetonide/ml medium and ''H-triamcinolone acetonide 
(1 t-tC;/ml medium) and then for 1 or 16 hr in steroid-free 
medium, harvested, and homogenized, after which the cytosol 
fraction was isolated. The amount of steroid found in the cytosol 
was very low. After 1 hr, recovery in cell cytosol amounted to 
0.05% of the amount originally present in 1 ml of the incubation 
medium, and after 16 hr to 0.02%. This value of0.02% represents 
an amount (about 800 pmoles/mg protein in the cell cytosol) , 
which could be sufficient to occupy all binding sites. This may 
explain why under these condi tions no specific binding was 
detected in the cells. 
When the steroid-free medium was renewed more frequently 
(3 times daily for 2 days), no 3H-triamcinolone acetonide was 
recovered from the cytosol fraction of these cells. Specific 
binding of 3H-triamcinolone acetonide was detected again. 
Available binding sites amounted to 170 fmoles/ mg protein, 
which is the level measured previously in cell cultures not 
exposed to glucocorticoids. 
DISCUSSION 
It has been suggested in the literature [8] and is now generally 
accepted that hormonal steroids exert their effect on the pro-
cesses in the living cell through binding to intracellular receptor 
proteins. Such proteins have been identified in various types of 
cell [9-14], and om results show that cultured human skin 
fibroblasts too contain a macromolecule that binds triamcino-
lone acetonide with high affini ty. The binding system appears 
to become saturated at concentrations of about 2 X 10- 8 M 
triamcinolone acetonide in cytosol at 0°C. The apparent binding 
constants (Kdiss. = 3 - 7 X 10- 9 M; Bnwx = 125 - 200 fmoles/mg 
protein) are in the range of those observed in other cell lines; 
e.g., mouse L929 fibroblasts [10], human embryonic fibroblasts 
[15], and, recently, in another human skin fibroblast cell line 
[14). 
In a preparation of disrupted cells the binding system is 
saturated at a steroid concentration which is too low to inhibit 
cell proliferation or collagen synthesis in intact cells [1,3). This 
apparent discrepancy in the responsiveness of cell growth to 
steroids and cytosol receptor occupancy may be due to differ-
ences in the experimental conditions. Intact cells were used for 
studies on cell proliferation and collagen synthesis at 37°C, 
whereas the binding studies were performed at 0°C in a cell-
free system. Theoretically, because of the higher temperature 
(37°C), the concentration necessary to achieve satmation in 
living cells must be higher than that in binding assays at 0°C. 
It is estimated that the increase in temperature may account 
for divergence by factors of 2 and 10 if, binding energy is 
assumed to be between 2 and 10 kcal/ mol, respectively, and 
only conformational changes take place. However, in binding 
studies done in intact mouse L929 fibroblasts the steroid con-
centration in the medium had to be at least a 10 to 50 tin1es 
higher for half-maximal saturation of the intracellular steroid 
binding system at 37°C [16] than for binding in a cell-free 
system at 0°C [17). This observation is in agreement with 
Pratt's suggestion that viable L929 cells keep the intracellular 
concentration of some steroids lower than in the medium [18, 
19]. Another study done in our laboratory [1] indicated that 
the growth of mouse L929 fibroblasts was inhibited by much 
lower concentrations of glucocorticoids than were required for 
the same effect in skin fibroblasts. The binding effect in the 
control of cell growth might therefore vary from one cell line to 
another. 
Previous studies have shown a correlation between the effect 
on cell proliferation in culture and the clinical efficacy of various 
glucocorticoids [1). The present study has shown a correlation 
for some but not all steroids between the displacement of aH-
triamcinolone acetonide and the potency of g1·owth inhibition 
or clinical efficacy (Fig 1). Hydrocortisone, which is not only 
the weakest growth inhibi tor but also the least clinically effec-
tive glucocorticoid, was also the poorest competitor in binding. 
However, t he difference between the clinical efficacy of hydro-
cortisone and of its 17-butyrate is much greater than thatfound 
for the displacement of 3H-triamcinolone acetonide; and clobe-
tasol-17-propionate did not block the binding of ''H-triamcino-
lone acetonide more strongly than did the clinically less potent 
betamethasone- 17 -valerate and triamcinolone acetonide. The 
pa1t ial discrepancy in the ability of various steroids to affect 
cell growth and the extent of displacement of '1H-tramcinolone 
acetonide at the binding sites might be related to the use of 
intact cells and a cell-free system, respectively. 
The various steroid derivates might penetrate to a different 
extent into intact cells or have a different intracellular distri-
bution. Caution should be exercised in extrapolating the effects 
of the steroids on cell growth to the clinical efficacy. Clinical 
efficacy may be determined in terms of vasoconstrictive and 
anti-inflammatory effects, but our data show that inhibition of 
cell growth may serve as a useful parameter for assessment of 
a clinical useful steroid [1]. 
The present study was designed to explore the mechanism 
underlying the inhibitory effects of glucocorticoids on cell 
growth . The presence of steroid high affinity binding sites with 
a limited capacity in human fibroblasts clearly supports the 
current consensus of opinion that these receptors are involved 
in the control of cell g1·owth. The glucocorticoid "receptor" 
system is present in the steroid-sensitive cells in the early 
growth stage. The number of these "receptor" sites declines 
considerably when a progressive insensitivity to glucocor ticoid 
g1·owth inhibition develops dming cell growth. 
In this respect it should be noted that Hackney eta! [10] and 
Pratt and Ishii (20] found that the proliferation of a steroid-
resistant strain of cells was not affected by glucocorticoids, and 
that these cells showed only abou t 10% of the binding displayed 
by the steroid-responsive cells. These findings favor an impli-
cation of the glucocorticoid receptor system in control of cell 
growth, but, as shown in the present study, a glucocorticoid-
insensit ive, high-density cell culture still has many binding 
sites. 
Our results show that some other mechanism may also be 
involved in the effect of steroids on cell proliferation. In the 
fu·st place, nandrolone, an anabolic steroid, inhibited cell pro-
liferation but did not show any affinity to the glucocorticoid 
binding sites. Therefore another steroid binding system may 
exert a control function on cell growth . Secondly, when the 
steroid-containing medium was renewed, the effect of the glu-
cocor ticoid on cell growth disappeared. This resistance to 
g1·owth inhibition induced by medium renewal was of a transient 
nature: the progeny of the steroid-insensitive cells were fully 
responsive to glucocorticoids. No specific binding was detected 
in a parallel series of cell cul tures after replacement of the 
growth medium with a steroid-free medium. However, specific 
binding sites became available again after prolongation of the 
washing procedure, i.e., after removal of retained steroid from 
cytosol binding sites. Since under these conditions the cells still 
have a steroid binding system, it remains to be established why 
cell growth becomes insensitive to glucocorticoids even when 
the fresh medium contains steroid to whose action the cells had 
previously responded. The fi ndings suggest that glucocorticoids 
may induce factors that are involved in control of cell g1·owth. 
Such factors ar e apparent ly lost and not renewed when the 
medium is changed. 
Furthermore, it cannot be excluded that the glucocorticoid 
insensitivity observed in high-density cell cultures or after 
replacement of the growth medium is due to a mechanism 
operating beyond the "steroid-receptor in teraction," fo r exam-
ple a defect in the association of the cytoplasmic steroid-recep-
tor complex with cell nuclear constituents or a disturbance in 
the expression of the genome or some other metabolic response 
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of the cell. Therefore, we conclude that it is very likely that in 
addition to growth control mediated by a specific glucocorticoid 
binding system there is also another steroid-associated mecha-
nism operative. 
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